The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Friday, August 14, 2026

Subject of the day

PAHC

Concerning the House

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

United States · www.pahc.com

The Long Run

FY 2014–2025 · 12 years

LineLatestCAGRTrend
Revenue$1.30B+6.5%
Gross profit$399.94M+6.1%
Operating income$71.85M+16.6%
Net income$32.61M+16.7%
Cash from ops$13.31M-13.7%
Quotation

$34.06

+0.26 (+0.8%)

52w hi$59.33
52w lo$28.40
Vol122.58K
As ofAug 13
The Verdict

Hold

Our score +0.13

Short-0.10
Medium+0.24
Long+0.38

computed 2026-08-13

By the Numbers

Phibro Animal Health Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

Market cap$1.38B
Enterprise value$2.08B
Trailing P/E14.62x
Forward P/E10.19x
EV / EBITDA8.87x
P / S (ttm)0.92x
Profit margin6.3%
Return on equity30.3%
Revenue growth+10.3%
Earnings growth+15.7%
Debt / equity217.97
Risk Metrics
Beta vs SPX1.16
Corr SPX0.36
Annual vol52.9%
Annual ret+48.5%
Sharpe0.92
Max DD-52.1%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.28
Sector+0.12
Technical+0.00
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$34.22$34.65$33.83$34.06122.58K
Aug 12$34.04$34.99$33.30$33.80180.60K
Aug 11$34.42$35.15$33.74100.77K
Aug 10$34.15$34.89$32.88$34.15167.40K
Aug 7$35.43$36.12$34.13$34.29231.30K